Thiogenesis Therapeutics, Corp.
TTIPF
$0.44
$0.02897.03%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.34% | 3.58% | 3.78% | 17.04% | 128.40% |
| Total Receivables | 62.39% | -2.25% | 404.29% | 56.04% | 113.38% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 258.82% | 400.00% | 645.59% | 116.14% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.55% | 4.28% | 6.29% | 18.00% | 128.77% |
|
|
|||||
| Total Current Assets | 15.55% | 4.28% | 6.29% | 18.00% | 128.77% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.55% | 4.28% | 6.29% | 18.00% | 128.77% |
|
|
|||||
| Total Accounts Payable | -66.91% | -14.69% | 33.46% | 457.43% | 302.21% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -66.91% | -14.69% | 33.46% | 471.62% | 302.21% |
|
|
|||||
| Total Current Liabilities | -66.91% | -14.69% | 33.46% | 471.62% | 302.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -66.91% | -14.69% | 33.46% | 471.62% | 302.21% |
|
|
|||||
| Common Stock & APIC | 24.83% | 21.39% | 26.59% | 38.24% | 80.45% |
| Retained Earnings | -43.68% | -49.04% | -63.43% | -84.78% | -66.32% |
| Treasury Stock & Other | 4,808.56% | 10,086.32% | 6,329.67% | 64.52% | -144.08% |
| Total Common Equity | 23.40% | 5.80% | 4.92% | -5.28% | 119.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.40% | 5.80% | 4.92% | -5.28% | 119.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.40% | 5.80% | 4.92% | -5.28% | 119.75% |
|
|
|||||